Statement of Organization, Functions, and Delegations of Authority, 50223-50224 [2011-20355]
Download as PDF
<![CDATA[
Federal Register / Vol. 76, No. 156 / Friday, August 12, 2011 / Notices
NICEATM–ICCVAM Web site (https://
iccvam.niehs.nih.gov).
Application Selection Process
References
WHO. 2010. Rabies vaccines: WHO
Position paper. Weekly Epidemiological
Record 85(32):309–320.
Dated: August 3, 2011.
John R. Bucher,
Associate Director, National Toxicology
Program.
[FR Doc. 2011–20540 Filed 8–11–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice To Change Catalog of Federal
Domestic Assistance (CFDA) Number
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice.
AGENCY:
This notice provides public
announcement of CDC’s intent to award
two awards to eligible applicants of
State or Territorial Public Health
Newborn Bloodspot Screening
Programs. These activities are proposed
by the above-mentioned grantees in
their FY 2011 applications submitted
under funding opportunity CDC–RFA–
EH11–001, ‘‘Program to Support New
Implementation of State or Territorial
Public Health Laboratory Capacity for
Newborn Bloodspot Screening of Severe
Combined Immune Deficiency (SCID)
(U01), ’’ Catalog of Federal Domestic
Assistance Number (CFDA): 93.070.
Approximately $900,000 in funding will
be awarded to the grantees for the
implementation of newborn screening
for SCID.
Accordingly, CDC adds the following
information to the previously published
funding opportunity announcement of
EH11–001:
SUMMARY:
Authority: Authorized under Section 301
of the Public Health Service Act, [42 U.S.C.
241], as amended.
CFDA #: 93.070 Environmental Public
Health Emergency Response.
mstockstill on DSK4VPTVN1PROD with NOTICES
Award Information
Type of Award: New Competing
Cooperative Agreement.
Approximate Total Current Fiscal
Year ACA Funding: $900,000.
Anticipated Number of Awards: 2.
Fiscal Year Funds: 2011.
Anticipated Award Date: September
1, 2011.
VerDate Mar<15>2010
16:37 Aug 11, 2011
Jkt 223001
Funding will be awarded to
applicants based on results from the
peer review panel ranking
recommendations.
Funding Authority
CDC will add the authority to that
which is reflected in the published
Funding Opportunity CDC–RFA–EH11–
001. The revised funding authority
language will read:
—Authorized under Section 301 of the
Public Health Service Act, [42 U.S.C.
241], as amended.
DATES: The effective date for this action
is the date of publication of this Notice
and remains in effect until the
expiration of the project period of the
funded applications.
FOR FURTHER INFORMATION CONTACT: Beth
Gardner, Extramural Team Lead,
National Center for Environmental
Health, Centers for Disease Control and
Prevention, 4770 Buford Hwy., Atlanta,
GA 30341, telephone (770) 488–0572, email Bgardner@cdc.gov.
SUPPLEMENTARY INFORMATION: None.
Dated: August 3, 2011.
James Stephens,
Director of the Office of Science Quality,
Centers for Disease Control and Prevention.
[FR Doc. 2011–20507 Filed 8–11–11; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Statement of Organization, Functions,
and Delegations of Authority
Part C (Centers for Disease Control
and Prevention) of the Statement of
Organization, Functions, and
Delegations of Authority of the
Department of Health and Human
Services (45 FR 67772–76, dated
October 14, 1980, and corrected at 45 FR
69296, October 20, 1980, as amended
most recently at 76 FR 47189–47190,
dated August 4, 2011) is amended to
reflect the reorganization of the Center
for Global Health, Centers for Disease
Control and Prevention.
Section C–B, Organization and
Functions, is hereby amended as
follows: After the title and functional
statements for the Division of Global
Disease Detection and Emergency
Response (CWJ), insert the following:
Global Immunization Division (CWK).
The Global Immunization Division
(GID) protects the health of Americans
and global citizens by preventing
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
50223
disease, disability, and death worldwide
from vaccine-preventable diseases. In
carrying out its mission, GID: (1)
Provides national leadership and
coordination of the CGH efforts to
eradicate polio, control or eliminate
measles, strengthen routine
immunization programs, introduce new
and under-utilized vaccines, and
promote safe injection practices, in
collaboration with international
organizations and CDC Centers/
Institute/Offices; (2) provides short- and
long-term consultation and technical
assistance to the WHO, UNICEF, and
foreign countries involved in global
immunization activities and participates
in international advisory group
meetings on immunization issues; (3)
administers grants to WHO, Pan
American Health Organization (PAHO),
UNICEF, and other international
partners as appropriate for the provision
of technical, programmatic, and
laboratory support, and vaccine
procurement for initiatives to support
global immunization targets; (4) designs
and participates in international
research, monitoring, and evaluation
projects to increase the effectiveness of
immunization strategies as may be
developed; (5) develops strategies to
improve the technical skills and
problem-solving abilities of program
managers and health care workers in
other countries; (6) refines strategies
developed for the eradication or control
of vaccine-preventable diseases in the
Western Hemisphere for
implementation in other parts of the
world; (7) assists other countries, WHO,
and other partners to improve
surveillance for polio, measles, and
other vaccine preventable diseases
(VPDs); (8) prepares articles based on
findings for publication in international
professional journals and presentation
at international conferences; (9)
collaborates with other countries, WHO,
UNICEF, and advocacy groups to ensure
the availability of sufficient funds to
purchase an adequate supply of polio,
measles, and other vaccines, and funds
for technical support for use in
eradication and control efforts; and (10)
provides technical and operational
leadership for CDC’s activities in
support of the immunization initiatives
such as Global Alliance for Vaccines
and Immunization and the Global
Immunization Vision and Strategies.
Office of the Director (CWK1). (1)
Provides leadership, management, and
oversight for all division activities; (2)
provides coordination of budgeting and
liaison with CGH, and FMO on budget
and spending; (3) provides coordination
and oversight of the division’s
E:\FR\FM\12AUN1.SGM
12AUN1
mstockstill on DSK4VPTVN1PROD with NOTICES
50224
Federal Register / Vol. 76, No. 156 / Friday, August 12, 2011 / Notices
personnel actions including liaison with
CGH and CDC’s human resource office;
(4) develops and promotes partnerships
with other organizations to support
global immunization activities; (5)
liaises and coordinates with other CDC
offices engaged in global immunization
activities; (6) provides coordination and
oversight of division research and
scientific publications, and liaison with
other CDC offices involved in scientific
oversight; (7) provides coordination of
the division communications activities
including liaison with other CDC
communications offices and those of our
partner agencies; (8) represents CDC,
CGH, and the division at global and
national meetings and other fora for
global immunization activities; and (9)
provides oversight for all Embassy/
International Cooperative
Administrative Supportive Services
costs for the division’s field staff.
Vaccine Preventable Disease
Eradication and Elimination Branch
(CWKB). (1) Plans, coordinates, and
directs, in collaboration with partners,
technical and programmatic activities to
eradicate or eliminate/control targeted
VPDS; (2) participates in developing
and implements improvements to
immunization services, surveillance,
monitoring, evaluation, and data
management program elements for
targeted diseases; (3) manages teams
that coordinate regional activities and
provide guidance and support to the
Vaccine Preventable Disease Eradication
and Elimination Branch (VPDEEB) staff
assigned in the European Region,
Eastern Mediterranean Region, African
Region, South East Asia Region, and
Western Pacific Region WHO regions;
(4) participates in multilateral
collaborations with an extensive array of
CDC and external partners engaged in
VPD eradication and elimination
including: participating countries, other
CDC organizations, other U.S.
Government organizations, international
organizations including WHO, the
United Nations Foundation, UNICEF,
and the World Bank; nongovernmental,
private sector organizations and vaccine
producers, and international advisory
committees; (5) provides subject-matter
expertise, short- and long-term
consultations, and coordinates
epidemiology, surveillance, and
laboratory activities for programs to
eradicate and eliminate VPDs; (6)
participates in operation research,
monitoring and evaluation projects and
studies to improve VPD eradication and
control programs and prepares articles
based on findings for publication in
international professional journals and
presentation at international
VerDate Mar<15>2010
16:37 Aug 11, 2011
Jkt 223001
conferences; (7) assists with outbreak
investigations and emergency response
activities; (8) provides technical
management for grants and cooperatives
agreements for vaccine procurement and
for provision of technical,
programmatic, and laboratory support.
Strengthening Immunization Systems
Branch (CWKC). (1) Develops and brings
to routine operational level, in
collaboration with partners, programs to
deliver established, newly available, or
under-utilized vaccines for diseases of
global importance; (2) assesses the
impact of immunization service delivery
through surveillance, monitoring of
vaccine coverage, and operations
research; (3) develops, evaluates, and
recommends improvements to
strengthen routine immunization
programs, including those related to
laboratory-based and integrated
surveillance systems; immunization
coverage, economic evaluations and
post-introduction evaluations; (4)
provides subject-matter expertise and
short- and long-term consultations; (5)
participates in multilateral
collaborations with an extensive array of
CDC and external partners engaged in
delivery of routine services,
surveillance, and coverage monitoring
of VPDs including: participating
countries, other CDC organizations,
other U.S. Government organizations,
international organizations including
WHO, the United Nations Foundation,
UNICEF, and the World Bank; nongovernmental, private sector
organizations and vaccine producers,
and international advisory committees;
(6) assists partner countries to build
capacity in the areas of service delivery,
surveillance, health information
systems, data management, laboratory
services and surveillance, and decisionmaking to achieve effective, efficient,
and sustainable immunization
programs; (7) manages and provides
guidance and support for the GID PAHO
team that coordinates PAHO regional
activities; (8) evaluates, in collaboration
with partners, projects that integrate
non-vaccine interventions with routine
immunization programs; (9) designs and
participates in research, monitoring and
evaluation projects and studies to
improve existing and newly developing
VPD control and eradication programs
and prepares articles based on findings
for publication in international
professional journals and presentation
at international conferences; (10) assists
with outbreak investigations and
emergency response activities.
Delete in its entirety the functional
statements for the Global Immunization
Division (CVGC) within the National
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
Center for Immunization and
Respiratory Diseases (CVG).
Dated: August 3, 2011.
Carlton Duncan,
Acting Chief Operating Officer, Centers for
Disease Control and Prevention.
[FR Doc. 2011–20355 Filed 8–11–11; 8:45 am]
BILLING CODE 4160–18–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–5502–N2]
Medicare Program; Accountable Care
Organization Accelerated Development
Learning Sessions; Center for
Medicare and Medicaid Innovation,
September 15th and 16th, 2011
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Notice of meeting.
AGENCY:
This notice announces the
date and location of the second in a
series of public educational sessions
hosted by the Centers for Medicare &
Medicaid Services (CMS). This two-day
training session is the second
Accelerated Development Learning
Session (ADLS) hosted by CMS to help
Accountable Care Organizations (ACOs)
deliver better care and reduce costs. We
invite all new or existing ACO entities
to register a team of senior executives to
attend the in-person ADLS. The ADLS
will provide executives with the
opportunity to learn about core
functions of an ACO and ways to build
their organization’s capacity to succeed
as an ACO.
DATES: Meeting Date: Thursday,
September 15, 2011, 8 a.m to 5 pm.,
pacific daylight time (p.d.t): Friday,
September 16, 2011, 8 a.m. to 5 p.m.
(p.d.t).
Deadline for Meeting Registration:
Registration for the second ADLS will
remain open until capacity has been
reached for the September 15 through
16 in-person meeting. Space is limited
and participants are encouraged to
register as soon as possible.
ADDRESSES: Meeting Location: The
second ADLS will be held at the Hyatt
Regency San Francisco Airport at 1333
Bayshore Highway, Burlingame, CA
94010. Participants are responsible for
their own travel, parking, meals, and
overnight stay expenses. More
information about the venue and
accommodations can be found at
https://acoregister.rti.org/. Potential
participants are also strongly
SUMMARY:
E:\FR\FM\12AUN1.SGM
12AUN1
]]>Agencies
[Federal Register Volume 76, Number 156 (Friday, August 12, 2011)]
[Notices]
[Pages 50223-50224]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-20355]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Statement of Organization, Functions, and Delegations of
Authority
Part C (Centers for Disease Control and Prevention) of the
Statement of Organization, Functions, and Delegations of Authority of
the Department of Health and Human Services (45 FR 67772-76, dated
October 14, 1980, and corrected at 45 FR 69296, October 20, 1980, as
amended most recently at 76 FR 47189-47190, dated August 4, 2011) is
amended to reflect the reorganization of the Center for Global Health,
Centers for Disease Control and Prevention.
Section C-B, Organization and Functions, is hereby amended as
follows: After the title and functional statements for the Division of
Global Disease Detection and Emergency Response (CWJ), insert the
following:
Global Immunization Division (CWK). The Global Immunization
Division (GID) protects the health of Americans and global citizens by
preventing disease, disability, and death worldwide from vaccine-
preventable diseases. In carrying out its mission, GID: (1) Provides
national leadership and coordination of the CGH efforts to eradicate
polio, control or eliminate measles, strengthen routine immunization
programs, introduce new and under-utilized vaccines, and promote safe
injection practices, in collaboration with international organizations
and CDC Centers/Institute/Offices; (2) provides short- and long-term
consultation and technical assistance to the WHO, UNICEF, and foreign
countries involved in global immunization activities and participates
in international advisory group meetings on immunization issues; (3)
administers grants to WHO, Pan American Health Organization (PAHO),
UNICEF, and other international partners as appropriate for the
provision of technical, programmatic, and laboratory support, and
vaccine procurement for initiatives to support global immunization
targets; (4) designs and participates in international research,
monitoring, and evaluation projects to increase the effectiveness of
immunization strategies as may be developed; (5) develops strategies to
improve the technical skills and problem-solving abilities of program
managers and health care workers in other countries; (6) refines
strategies developed for the eradication or control of vaccine-
preventable diseases in the Western Hemisphere for implementation in
other parts of the world; (7) assists other countries, WHO, and other
partners to improve surveillance for polio, measles, and other vaccine
preventable diseases (VPDs); (8) prepares articles based on findings
for publication in international professional journals and presentation
at international conferences; (9) collaborates with other countries,
WHO, UNICEF, and advocacy groups to ensure the availability of
sufficient funds to purchase an adequate supply of polio, measles, and
other vaccines, and funds for technical support for use in eradication
and control efforts; and (10) provides technical and operational
leadership for CDC's activities in support of the immunization
initiatives such as Global Alliance for Vaccines and Immunization and
the Global Immunization Vision and Strategies.
Office of the Director (CWK1). (1) Provides leadership, management,
and oversight for all division activities; (2) provides coordination of
budgeting and liaison with CGH, and FMO on budget and spending; (3)
provides coordination and oversight of the division's
[[Page 50224]]
personnel actions including liaison with CGH and CDC's human resource
office; (4) develops and promotes partnerships with other organizations
to support global immunization activities; (5) liaises and coordinates
with other CDC offices engaged in global immunization activities; (6)
provides coordination and oversight of division research and scientific
publications, and liaison with other CDC offices involved in scientific
oversight; (7) provides coordination of the division communications
activities including liaison with other CDC communications offices and
those of our partner agencies; (8) represents CDC, CGH, and the
division at global and national meetings and other fora for global
immunization activities; and (9) provides oversight for all Embassy/
International Cooperative Administrative Supportive Services costs for
the division's field staff.
Vaccine Preventable Disease Eradication and Elimination Branch
(CWKB). (1) Plans, coordinates, and directs, in collaboration with
partners, technical and programmatic activities to eradicate or
eliminate/control targeted VPDS; (2) participates in developing and
implements improvements to immunization services, surveillance,
monitoring, evaluation, and data management program elements for
targeted diseases; (3) manages teams that coordinate regional
activities and provide guidance and support to the Vaccine Preventable
Disease Eradication and Elimination Branch (VPDEEB) staff assigned in
the European Region, Eastern Mediterranean Region, African Region,
South East Asia Region, and Western Pacific Region WHO regions; (4)
participates in multilateral collaborations with an extensive array of
CDC and external partners engaged in VPD eradication and elimination
including: participating countries, other CDC organizations, other U.S.
Government organizations, international organizations including WHO,
the United Nations Foundation, UNICEF, and the World Bank;
nongovernmental, private sector organizations and vaccine producers,
and international advisory committees; (5) provides subject-matter
expertise, short- and long-term consultations, and coordinates
epidemiology, surveillance, and laboratory activities for programs to
eradicate and eliminate VPDs; (6) participates in operation research,
monitoring and evaluation projects and studies to improve VPD
eradication and control programs and prepares articles based on
findings for publication in international professional journals and
presentation at international conferences; (7) assists with outbreak
investigations and emergency response activities; (8) provides
technical management for grants and cooperatives agreements for vaccine
procurement and for provision of technical, programmatic, and
laboratory support.
Strengthening Immunization Systems Branch (CWKC). (1) Develops and
brings to routine operational level, in collaboration with partners,
programs to deliver established, newly available, or under-utilized
vaccines for diseases of global importance; (2) assesses the impact of
immunization service delivery through surveillance, monitoring of
vaccine coverage, and operations research; (3) develops, evaluates, and
recommends improvements to strengthen routine immunization programs,
including those related to laboratory-based and integrated surveillance
systems; immunization coverage, economic evaluations and post-
introduction evaluations; (4) provides subject-matter expertise and
short- and long-term consultations; (5) participates in multilateral
collaborations with an extensive array of CDC and external partners
engaged in delivery of routine services, surveillance, and coverage
monitoring of VPDs including: participating countries, other CDC
organizations, other U.S. Government organizations, international
organizations including WHO, the United Nations Foundation, UNICEF, and
the World Bank; non-governmental, private sector organizations and
vaccine producers, and international advisory committees; (6) assists
partner countries to build capacity in the areas of service delivery,
surveillance, health information systems, data management, laboratory
services and surveillance, and decision-making to achieve effective,
efficient, and sustainable immunization programs; (7) manages and
provides guidance and support for the GID PAHO team that coordinates
PAHO regional activities; (8) evaluates, in collaboration with
partners, projects that integrate non-vaccine interventions with
routine immunization programs; (9) designs and participates in
research, monitoring and evaluation projects and studies to improve
existing and newly developing VPD control and eradication programs and
prepares articles based on findings for publication in international
professional journals and presentation at international conferences;
(10) assists with outbreak investigations and emergency response
activities.
Delete in its entirety the functional statements for the Global
Immunization Division (CVGC) within the National Center for
Immunization and Respiratory Diseases (CVG).
Dated: August 3, 2011.
Carlton Duncan,
Acting Chief Operating Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2011-20355 Filed 8-11-11; 8:45 am]
BILLING CODE 4160-18-M
